Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study — Stella

Home/Alzheimer's Disease/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer's Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

CSMC, Los Angeles, California

Key details

Sponsor

Cedars-Sinai Medical Center

Enrollment target

~45 participants

Started

December 2025

Primary completion

August 2026

Age range

55 Years – 89 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.